Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 03, 2013 17:30 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces First Quarter 2013 Results

TORONTO, April 3, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
March 25, 2013 14:52 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Closes US$3.1 Million Registered Direct Offering of Units

TORONTO, March 25, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
March 19, 2013 09:07 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics to Raise US$3.1 Million

TORONTO, March 19, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
March 13, 2013 18:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Update on Its Generic Versions of Keppra XR(R) and Pristiq(R)

TORONTO, March 13, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
January 31, 2013 21:52 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces 2012 Year End Results

TORONTO, Jan. 31, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
January 10, 2013 17:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Closes US$1.5 Million Convertible Debenture Financing

TORONTO, Jan. 10, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
January 07, 2013 08:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Proposed Convertible Debenture Financing

TORONTO, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...
November 27, 2012 07:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Results of Initial Phase I Clinical Trial of Controlled-Release Pregabalin and Product Updates

TORONTO, Nov. 27, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
November 21, 2012 07:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics to Present at the 24th Annual Piper Jaffray Healthcare Conference

TORONTO, Nov. 21, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
October 02, 2012 17:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Third Quarter 2012 Results

TORONTO, Oct. 2, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...